Table 4. Clinicopathologic information of breast IDC patients.
| Clinicopathologic information | Case No. (percentage) |
|---|---|
| Tumor Size(cm) | |
| Less than 2 | 186(0.3503) |
| 2 to 5 | 246(0.4633) |
| More than 5 | 30(0.5650) |
| Unknown | 69(0.1299) |
| LN involvement | |
| Positive | 273(0.5141) |
| Negative | 198(0.3729) |
| Unknown | 60(0.1130) |
| ER | |
| Positive | 277(0.5217) |
| Negative | 189(0.3559) |
| Unknown | 65(0.1224) |
| PR | |
| Positive | 327(0.6158) |
| Negative | 137(0.2580) |
| Unknown | 67(0.1262) |
| P53 | |
| Positive | 143(0.2693) |
| Negative | 314(0.5913) |
| Unknown | 74(0.1394) |
| CerbB-2 | |
| Positive | 171(0.3220) |
| Negative | 292(0.5499) |
| Unknown | 68(0.1281) |
IDC infiltrative ductal carcinoma, LN lymph node, TZ tumor size, ER estrogen receptor, PR progesterone receptor.